New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
10:30 EDTDKS, PSDV, NI, INOHigh option volume stocks: INO NI DKS KOL PSDV
News For PSDV;INO;NI;DKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
08:09 EDTDKSDick's Sporting realistic long-term targets positive, says UBS
UBS said the new realistic long-term targets set by Dick's Sporting are a positive, as they set the foundation for a favorable earnings revision cycle. UBS reiterated its Buy rating and $67 price target on Dick's Sporting shares.
April 14, 2015
08:09 EDTPSDVpSivida reports ILUVIEN for DME approved in Poland
Subscribe for More Information
07:37 EDTDKSDick's Sporting backs FY15 EPS $3.10-$3.20, consensus $3.20
The company's earnings per share guidance includes the expectation of approximately $100M-200M of share repurchases in 2015. Consolidated SSS are currently expected to increase 1 to 3% in fiscal 2015.
07:36 EDTDKSDick's Sporting backs Q1 EPS 49c-53c, consensus 53c
Subscribe for More Information
07:36 EDTDKSDick's Sporting expects to invest $850M in net CapEx over next three years
DICK'S Sporting Goods also reaffirmed its capital allocation strategy to provide returns to shareholders through investing in the business, repurchasing shares and paying dividends. To drive the growth of the business the company expects to invest approximately $850M in net capital expenditures over the next three years, primarily in new stores, store remodels and eCommerce. With its $1B 5-year share repurchase authorization, the company targets share repurchases of $100 to 200 million annually. The company is also committed to quarterly dividends.
07:35 EDTDKSDick's Sporting expects to open 9 Specialty Concept stores in 2015
Subscribe for More Information
07:34 EDTDKSDick's Sporting plans to have ecommerce site on own platform in January 2017
Subscribe for More Information
07:34 EDTDKSDick's Sporting sees significant opportunity to increase market share in US
The company sees significant opportunity to increase market share in the U.S. through growing its DICK'S Sporting Goods store base in new and underpenetrated markets and increasing its eCommerce sales. Stores continue to be a very profitable growth vehicle that deliver strong new store productivity, accelerate eCommerce growth, build brand equity and customer loyalty, and reinforce the strength of the Company's vendor partnerships. The company is taking a measured approach to growing its store count and anticipates growing its DICK'S Sporting Goods store base to approximately 735 to 750 stores by the end of fiscal 2017, an increase of approximately 135 to 150 stores from the 603 stores at the end of fiscal 2014. The company plans to grow eCommerce sales to approximately $1B-1.2B in fiscal 2017, from $628 million in fiscal 2014.
07:32 EDTDKSDick's Sporting sees FY17 revenue $8.7B-$9B, 3-year EPS CAGR of 12%-16%
Subscribe for More Information
April 13, 2015
08:32 EDTDKSUnder Armour rises after Spieth brings attention to golf gear
Subscribe for More Information
April 11, 2015
14:02 EDTDKSDick's Sporting to host analyst meeting
Subscribe for More Information
April 10, 2015
07:31 EDTDKSDick's Sporting long-term positioning underappreciated, says UBS
Subscribe for More Information
April 9, 2015
08:08 EDTINOInovio says HPV Immunotherapy activates robust in vivo T cell responses
Inovio Pharmaceuticals announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer associated with human papillomavirus (HPV) types 16 and 18. INO-3112, an active immunotherapy that targets HPV 16 and 18 and simultaneously expresses IL-12, is designed to activate in vivo immune responses to antigens from high risk HPV types and eliminate precancerous and cancerous cells displaying these antigens. The magnitude and characteristics of these interim immune response data mirror immune responses previously observed in human studies of VGX-3100 for HPV-associated cervical dysplasia; in a placebo-controlled phase II study, strong T cell immune responses were positively correlated with achievement of primary and secondary efficacy endpoints, the company said. The data, which are T cell measurements from the first four treated patients of this phase I/IIa study, are being presented today at the World Vaccine Congress 2015 by Inovio COO, Dr. Niranjan Sardesai.
April 8, 2015
19:46 EDTINOOn The Fly: After Hours Movers
UP AFTER EARNINGS: Apogee (APOG), up 6.4%... Pier 1 Imports (PIR), up 4.4%. ALSO HIGHER: Inovio Pharmaceuticals (INO), up 5.6% after being selected by DARPA to lead $45M Ebola prevention program. DOWN AFTER EARNINGS: Alcoa (AA), down 3.5%... Bed Bath & Beyond (BBBY), down 3.5%. ALSO LOWER: Zynga (ZNGA), down 10.3% after announcing CEO transition... Memorial Production (MEMP), down 2.9% after filing to sell 4.6M common units owned by MRD Holdco... Regulus (RGLS), down 2.2% after filing to sell 3.3M shares for Isis Pharmaceuticals.
09:20 EDTINOOn The Fly: Pre-market Movers
Subscribe for More Information
06:06 EDTINOInovio selected by DARPA to lead $45M Ebola prevention program
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use